Neonc Technologies Holdings, Inc. (NTHI): Capital Expenditures

Annual figures by period end, from SEC filings.

$500.0K

Year ended 2025-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2025-12-31	$500.0K	n/a	2026-03-31, From 2025-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Capital Expenditures	Change YoY
Neonc Technologies Holdings, Inc. (NTHI)	2025-12-31	$500.0K	n/a
Altimmune, Inc. (ALT)	2025-12-31	$11.0K	n/a
Lyell Immunopharma, Inc. (LYEL)	2025-12-31	$780.0K	+68.1%
HCW Biologics Inc. (HCWB)	2025-12-31	$0	-100.0%
Talphera, Inc. (TLPH)	2024-12-31	$0	-100.0%
Connect Biopharma Holdings Ltd (CNTB)	2025-12-31	$434.0K	-42.1%
Inovio Pharmaceuticals, Inc. (INO)	2025-12-31	$285.7K	-41.4%
Skinvisible, Inc. (SKVI)	2025-12-31	$4.1K	-55.7%
Incannex Healthcare Inc. (IXHL)	2025-06-30	$8.0K	-97.1%

Compare NTHI, ALT, LYEL, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗